Condition: Long COVID · Sars-CoV-2 Infection · Coronavirus Infections · Sponsor: Wes Ely
The overarching goal of this study is to determine if baricitinib, as compared to placebo, will improve neurocognitive function, along with measures of physical function, quality of life, post-exertional malaise, effect of breathlessness on daily activities, post-COVID-19 symptom burden, and biomarkers of inflammation and viral measures, in participants with Long COVID.
This description comes directly from the study's public registry record.
Amanda Bistran-Hall · 615-343-8010 · vccrvlcstudy@vumc.org
Wes Ely, M.D.
Always discuss trial participation with your own doctor first.
| University of Arizona | Tucson, Arizona, United States | Recruiting |
| University of California, Los Angeles (UCLA) | Los Angeles, California, United States | Recruiting |
| University of California San Francisco | San Francisco, California, United States | Recruiting |
| University of Colorado I Anschutz Medical Campus | Aurora, Colorado, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| University of Florida College of Medicine | Gainesville, Florida, United States | Recruiting |
| Emory University | Atlanta, Georgia, United States | Recruiting |
| Illinois Research Network (ILLInet), University of Illinois Chicago | Chicago, Illinois, United States | Recruiting |
| Brigham and Women's Hospital | Boston, Massachusetts, United States | Recruiting |
| University of Minnesota | Minneapolis, Minnesota, United States | Recruiting |
| NYU Langone Health - Brooklyn | Brooklyn, New York, United States | Recruiting |
| University Hospitals Cleveland Case Western | Cleveland, Ohio, United States | Recruiting |
+ 5 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06631287